EU to release EUR 11.7 million for diabetes research
The European Commission has announced the launch of a five-year €11.7 million “Integrated project” to look into the treatment of obesity, one of the main causes of diabetes. The project will help identify brain mechanisms affecting obesity. The announcement ties in with World Diabetes Day on November 14th, which aims to raise public awareness of the causes, symptoms, treatment and complications associated with diabetes. The European Union has been supporting diabetes research for several years through its Research Framework Programmes. During the last four years alone, it has invested €40 million in 19 projects in this field. The 6th Framework Programme (FP6 2003-2006) allocates €2.225 billion to health research, including diabetes. The Integrated project on obesity and diabetes includes 24 partners from ten European countries. It is now being negotiated, and it will start its ambitious research activities early 2004.
“Considerable progress in treating diabetes has been achieved through innovative research but more research is needed to address the unmet needs of patients,” says European Research Commissioner Philippe Busquin. “Obesity ranks high among the causes of diabetes. It is a major risk factor and the reduction of weight often improves blood sugar control, thereby helping in the treatment of diabetes. This new research project is a first example of the European Research Area in action in the field of diabetes. Major players in this medical area will join forces and help make a change in the treatment of this illness at European level.”
Diabetes on the rise in Europe
The number of European citizens suffering from diabetes is rising. Most patients are affected by “type 2” diabetes. World Diabetes Day, supported by the World Health Organisation (WHO) and the International Diabetes Federation (IDF), is an annual awareness campaign to keep up the fight against diabetes. Many people do not even know they have high blood sugar levels and diabetes. Untreated diabetes can lead to serious long-term consequences and this year’s World Diabetes Day is focusing on kidney disease.
One of the reasons more and more Europeans are developing diabetes is that people’s average weight has increased. With increasing weight and obesity, in many cases the body is no longer able to maintain normal (low) blood sugar levels. A promising treatment of “type 2” diabetes is weight reduction. However, it is often difficult for patients to reduce weight and even more difficult to avoid a rapid rebound after weight reduction, for instance at the end of a diet.
EU funded research to combat diabetes
On a European Union level, research funding is available through the multi-annual Framework Programmes. Through the Fifth Research Framework Programme (1998-2002) 19 projects related to diabetes were supported, covering a wide range of topics. The total funding for these projects was almost €40 million. The goal of the Sixth Research Framework Programme (FP6, 2002-2006) is to aid the creation of the European Research Area (ERA) through new funding instruments, Integrated Projects and Networks of Excellence.
Fresh money for diabetes research
The European Commission has tackled research needs in the field of diabetes and obesity with a first call for proposals earlier this year. Following evaluation, the Commission is now involved with negotiations to fund an Integrated Project with an EU contribution of €11.7 million. The scientific basis for the project under negotiation is the knowledge that specific brain regions play an important role in weight regulation. The project aims at investigating the details of the regulatory circuits and to exploit this knowledge for the validation of targets for the treatment of obesity.
To achieve this goal, the project brings together 24 partners from 10 European countries. It integrates advanced genomic approaches with detailed analysis of sample patient groups and genetic research in animal models. Over five years, the project aims at validating several novel targets for drug development in this field, which is of high importance for public health in Europe.
Further calls for proposals
Three further calls during the Sixth Framework Programme will help strengthen the European Research Area as regards to diabetes research for the benefit of patients. In addition to supporting research through the new funding instruments, further projects are being supported through the traditional instruments, which are smaller in scope and funding. Research on “type 1” diabetes will also be supported within FP6.
Alle Nachrichten aus der Kategorie: Förderungen Preise
Ein Hygieneprogramm für Chromosomen
ETH-Forschende haben in Wirbeltierzellen ein neues zelluläres Kompartiment identifiziert, das Exklusom genannt wird und ein Vorläufer des heutigen eukaryotischen Zellkerns sein könnte. Die Studie zeigt: Säugetierzellen erkennen, bündeln und sortieren…
Weiblicher Resilienz auf der Spur
Organ-on-Chip-Technologie ermöglicht neue Einblicke. Dynamische Resilienz – dahinter verbirgt sich die Widerstandskraft menschlicher Körper gegenüber unvorhergesehenen Veränderungen oder Stressfaktoren. Ältere Menschen und speziell Frauen nach der Menopause sind aufgrund einer…
3D-Druck im Bauwesen: Pionierforschung für das Bauen der Zukunft
Statt Stein auf Stein per Hand gemauert, Schicht um Schicht mit dem Roboter 3D-gedruckt. So könnte die Zukunft des Bauens aussehen. Die ersten Bauten in Deutschland stehen bereits, kürzlich wurde…